Effects of sargentgloryvine stem extracts on HepG-2 cells in vitro and in vivo

Figure 6 Tumor growth inhibition by systemic sargentgloryvine stem extract-treatment in vivo. HepG-2 xenograft tumor (approximately 300 mm³) growth in Athymic BALB/c nude mice injected with 50 μL of 18 mg/kg sargentgloryvine stem extract (SSE) or DMEM-control every 2 d for 14 d. The tumor size was measured and the tumor volume was calculated as: width²× length × 0.5. ^aP < 0.05, ^bP < 0.01 vs DMEM control.